TL-HEM 150 Caplets | TL-HEM 150
R Only
TL-HEM 150 caplets are oval, beige, film-coated caplets debossed "TL606" .
| Each caplet for oral administration contains: | |
| Vitamin C (ascorbic acid) | 500 mg |
| Vitamin E (dl-alpha tocopheryl acetate) | 30 IU |
| Folic Acid | 1 mg |
| Vitamin B12 (cyanocobalamin) | 60 mcg |
| Biotin | 150 mcg |
| Iron (carbonyl iron) | 150 mg |
| Copper (cupric sulfate) | 3 mg |
| Docusate Sodium | 50 mg |
Microcrystalline Cellulose, Polyvinyl Alcohol, TriPotassium Citrate, Citric Acid, Titanium Dioxide, Povidone, Acacia, Stearic Acid, Fumed Silica, Magnesium Stearate, Talc, Polyethylene Glycol, FD&C Yellow #6, FD&C Blue #2.
TL-HEM 150 is indicated in the treatment of most megaloblastic, macrocytic and iron-deficiency anemias, in the anemias of pregnancy, in those anemias occurring in a variety of malabsorption syndromes, and those of nutritional origin. It is a useful adjuvant in patients in whom erythropoiesis is suppressed due to severe infections, malignancies or to the toxic effects of certain chemotherapeutic agents. A deficiency of Vitamin E may increase the fragility of red blood cells, with resultants enhanced hemolysis.
TL-Hem 150 is a hematinic preparation containing multiple ingredients essential to normal erythropoiesis, plus a stool softener to counteract the possible constipating effects of iron. Vitamin C is present to aid the absorption of iron.
This product is contraindicated in patients with a known hypersensitivity to any of the ingredients.
Folic acid alone is improper therapy in the treatment of pernicious anemia and other megaloblastic anemias where vitamin B is deficient. Folic acid in doses above 1.0 mg daily may obscure pernicious anemia in that hematologic remission can occur while neurological manifestations remain progressive.
Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6. KEEP THIS PRODUCT OUT OF REACH OF CHILDREN. In case of accidental overdose, call a doctor or poison control center immediately.
Do not exceed recommended dose.
Some patients affected with pernicious anemia may not respond to orally administered Vitamin B with intrinsic factor concentrate and there is no known way to predict which patients will respond or which patients may cease to respond. Periodic examinations, laboratory studies of pernicious anemia patients are essential and recommended. If any symptoms of intolerance occur, the drug should be temporarily or permanently discontinued, which should be determined by a physician.
Safety and effectiveness in pediatric patients with this product have not been established.
Sufficient clinical studies on this product have not been performed in sufficient numbers of subjects aged 65 and over to determine whether elderly subjects respond differently from younger subjects. In general, dose selection for an elderly patient should be cautious, usually starting at the low end of the dosing range, reflecting the greater frequency of decreased hepatic, renal, or cardiac functions, and of concomitant disease or other drug therapy.
Adverse reactions with iron therapy may include gastrointestinal intolerance, diarrhea, nausea, vomiting, dark stools and abdominal pain. Skin rashes of various types may occur. Such reactions may necessitate temporary or permanent changes in dosage or usage. Allergic sensitization has been reported following both oral and parenteral administration of folic acid.
One caplet daily or as prescribed by a physician.
TL-HEM 150 is supplied in bottles of 90 caplets.
NDC 13811-606-90
Store at Controlled Room Temperature 15°-30° C (59°- 86°F). [See USP].
Call your doctor about side effects. You may report side effects by calling 888 9 TRIGEN (888-987-4436).
KEEP THIS AND ALL DRUGS OUT OF THE REACH OF CHILDREN.
R Only
All prescriptions using this product shall be pursuant to state statutes as applicable. This is not an Orange Book product. There are no implied or explicit claims on therapeutic equivalence.
Manufactured for: TRIGEN Laboratories, Inc. Sayreville, NJ 08872 www.trigenlab.com
Rev. 01/11
NDC 13811-606-90
TL-HEM 150
R Only
TRIGEN LABORATORIES
90 CAPLETS
Manufacturer
TRIGEN Laboratories, Inc.
Active Ingredients
Source
- U.S. National Library of Medicine
- DailyMed
- Last Updated: 4 May 2013
Drugs and Medications
Anti-bacterial moisturizing hand [Bath & Body Works, Inc.]
DRUG FACTS
Iope mild clinic sun protector [AMOREPACIFIC]
IOPE MILD CLINIC SUN PROTECTOR
Dial clear and refresh antibacterial hand soap [The Dial Corporation]
Drug Facts
Tolnaftate antifungal [MAJOR Pharmaceuticals Inc.]
Drug Facts
Clinical Trials
The Utility of Peri-operative Arnica Montana for Reduction of Ecchymosis in Rhinoplasty Surgery
Arnica montana is a homeopathic drug that is made in accordance with the official methods of the Homeopathic Pharmacopoeia of the United States (HPUS) and is commonly used by cosmetic surg...
Pharyngeal Size in Patients With Obstructive Tonsils Under Orthodontic Treatment
Enlarged tonsils and malocclusion has relationship with sleep disturbance in children. The consequences of these features can include aggravation of craniofacial growth such that the devel...
The Biology of Chronic Preconditioning: Genomic and Physiologic Mechanisms of Response
The purpose of this study is to assess the effects of repeated RIPC and exercise, on exercise performance, skeletal muscle responses and circulating cellular and humoral biology in humans
Pilot Study of Raltegravir Lipodystrophy IISP
The substitution of raltegravir for the NRTIs will result in some reversal of the long term adverse effect of lipodystrophy (specifically peripheral lipoatrophy) that is associated with th...
Brief Summary: RATIONALE: Comparing results of diagnostic procedures, such as esophagoscopy, done before and after radiation therapy and/or chemotherapy may help doctors predict a patient...
PubMed Articles
Spelling out the rules. Regulations detail how law will protect consumers.
Road map to better care. U.S. at bottom of Commonwealth Fund's ranking of seven health systems.
Orszag exit looms...as speculation grows over effect on health reform.
